These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 28714932)

  • 1. Thrombospondins: A Role in Cardiovascular Disease.
    Chistiakov DA; Melnichenko AA; Myasoedova VA; Grechko AV; Orekhov AN
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28714932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombospondins, potential drug targets for cardiovascular diseases.
    Mustonen E; Ruskoaho H; Rysä J
    Basic Clin Pharmacol Toxicol; 2013 Jan; 112(1):4-12. PubMed ID: 23074998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In the balance: how do thrombospondins contribute to the cellular pathophysiology of cardiovascular disease?
    Forbes T; Pauza AG; Adams JC
    Am J Physiol Cell Physiol; 2021 Nov; 321(5):C826-C845. PubMed ID: 34495764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of thrombospondin‑1 and thrombospondin‑2 in cardiovascular diseases (Review).
    Zhang K; Li M; Yin L; Fu G; Liu Z
    Int J Mol Med; 2020 May; 45(5):1275-1293. PubMed ID: 32323748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombospondins in the transition from myocardial infarction to heart failure.
    Kirk JA; Cingolani OH
    J Mol Cell Cardiol; 2016 Jan; 90():102-10. PubMed ID: 26686988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombospondin immune regulation and the kidney.
    Ponticelli C; Anders HJ
    Nephrol Dial Transplant; 2017 Jul; 32(7):1084-1089. PubMed ID: 28088772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor-2 regulates human cardiac myofibroblast-mediated extracellular matrix remodeling.
    Svystonyuk DA; Ngu JM; Mewhort HE; Lipon BD; Teng G; Guzzardi DG; Malik G; Belke DD; Fedak PW
    J Transl Med; 2015 May; 13():147. PubMed ID: 25948488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the extracellular matrix patterning of thrombospondins by actin dynamics and thrombospondin oligomer state.
    Hellewell AL; Gong X; Schärich K; Christofidou ED; Adams JC
    Biosci Rep; 2015 May; 35(3):. PubMed ID: 26182380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation.
    Wu D; Lei H; Wang JY; Zhang CL; Feng H; Fu FY; Li L; Wu LL
    J Mol Med (Berl); 2015 Dec; 93(12):1311-25. PubMed ID: 26138247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced expression of ephrins and thrombospondins in the dermis of patients with early diffuse systemic sclerosis: potential contribution to perturbed angiogenesis and fibrosis.
    Avouac J; Clemessy M; Distler JH; Gasc JM; Ruiz B; Vacher-Lavenu MC; Wipff J; Kahan A; Boileau C; Corvol P; Allanore Y
    Rheumatology (Oxford); 2011 Aug; 50(8):1494-504. PubMed ID: 21454305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thrombospondins: multimodular proteins with angiostatic function].
    Feige JJ
    Pathol Biol (Paris); 1999 Apr; 47(4):339-44. PubMed ID: 10372402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombospondin-4, tumour necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14: novel extracellular matrix modulating factors in cardiac remodelling.
    Mustonen E; Ruskoaho H; Rysä J
    Ann Med; 2012 Dec; 44(8):793-804. PubMed ID: 22380695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous thrombospondin 1 protects the pressure-overloaded myocardium by modulating fibroblast phenotype and matrix metabolism.
    Xia Y; Dobaczewski M; Gonzalez-Quesada C; Chen W; Biernacka A; Li N; Lee DW; Frangogiannis NG
    Hypertension; 2011 Nov; 58(5):902-11. PubMed ID: 21947471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombospondins and tumor angiogenesis.
    de Fraipont F; Nicholson AC; Feige JJ; Van Meir EG
    Trends Mol Med; 2001 Sep; 7(9):401-7. PubMed ID: 11530335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiological roles of thrombospondin-4 in disease development.
    Genaro K; Luo ZD
    Semin Cell Dev Biol; 2024 Mar; 155(Pt B):66-73. PubMed ID: 37391348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombospondin-4 in tissue remodeling.
    Stenina-Adognravi O; Plow EF
    Matrix Biol; 2019 Jan; 75-76():300-313. PubMed ID: 29138119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TSP1 and TSP2 deficiencies affect LOX protein distribution in the femoral diaphysis and pro-peptide removal in marrow-derived mesenchymal stem cells in vitro.
    Shearer D; Mervis MO; Manley E; Reddy AB; Alford AI
    Connect Tissue Res; 2019 Sep; 60(5):495-506. PubMed ID: 30939949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombospondins: old players, new games.
    Stenina-Adognravi O
    Curr Opin Lipidol; 2013 Oct; 24(5):401-9. PubMed ID: 23892609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functions of the conserved thrombospondin carboxy-terminal cassette in cell-extracellular matrix interactions and signaling.
    Adams JC
    Int J Biochem Cell Biol; 2004 Jun; 36(6):1102-14. PubMed ID: 15094125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the thrombospondins in healing myocardial infarcts.
    Chatila K; Ren G; Xia Y; Huebener P; Bujak M; Frangogiannis NG
    Cardiovasc Hematol Agents Med Chem; 2007 Jan; 5(1):21-7. PubMed ID: 17266545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.